David Dornan Elevation Oncology, Inc. (ELEV) insider trading activity

ELEV Quotes by TradingView

David Dornan is CHIEF SCIENTIFIC OFFICER of Elevation Oncology, Inc.. Currently has a direct ownership of 5,223 shares of ELEV, which is worth approximately $2,820. The most recent transaction as insider was on Feb 15, 2025, when has been sold 4,152 shares (Common Stock) at a price of $0.67 per share, resulting in proceeds of $2,781. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.22K
n/a 3M change
n/a 12M change
Total Value Held $2,820

David Dornan Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 15 2025
SELL
Payment of exercise price or tax liability
$2,781 $0.67 p/Share
4,152 Reduced 44.29%
5,223 Common Stock
Feb 15 2025
BUY
Exercise of conversion of derivative security
-
9,375 Added 50.0%
9,375 Common Stock

Also insider at

BOLT
Bolt Biotherapeutics, Inc. Healthcare
Chief Scientific Officer
DD

David Dornan

CHIEF SCIENTIFIC OFFICER
Redwood City, CA

Track Institutional and Insider Activities on ELEV

Follow Elevation Oncology, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ELEV shares.

Notify only if

Insider Trading

Get notified when an Elevation Oncology, Inc. insider buys or sells ELEV shares.

Notify only if

News

Receive news related to Elevation Oncology, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ELEV